Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 5/20 | 0.45 |
| ▸ | CYP2D6 | P10635 | 4/20 | 0.45 |
| ▸ | MAPT | P10636 | 4/20 | 0.45 |
| ▸ | SPHK1 | Q9NYA1 | 3/20 | 0.45 |
| ▸ | GMNN | O75496 | 3/20 | 0.45 |
| ▸ | POLB | P06746 | 3/20 | 0.45 |
| ▸ | BLM | P54132 | 3/20 | 0.45 |
| ▸ | CETP | P11597 | 3/20 | 0.45 |
| ▸ | UBE2N | P61088 | 3/20 | 0.45 |
| ▸ | THPO | P40225 | 2/20 | 0.45 |
| ▸ | TP53 | P04637 | 2/20 | 0.45 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.45 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.45 |
| ▸ | MTOR | P42345 | 1/20 | 0.45 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.45 |
| ▸ | HTT | P42858 | 1/20 | 0.45 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.36 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.35 |
| ▸ | MEN1 | O00255 | 3/20 | 0.34 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14753821 | 1.00 | LMNA (0.45) | LMNACYP2D6MAPTSPHK1GMNN | |
| SCHEMBL12009794 | 1.00 | LMNA (0.45) | LMNACYP2D6MAPTSPHK1GMNN | |
| SCHEMBL14543846 | 1.00 | LMNA (0.45) | LMNACYP2D6MAPTSPHK1GMNN | |
| SCHEMBL10123410 | 0.83 | — | — | |
| SCHEMBL16367524 | 0.83 | TSHR (0.35) | LMNACYP2D6MAPTSPHK1GMNN | |
| SCHEMBL12493240 | 0.83 | — | — | |
| SCHEMBL14753828 | 0.83 | — | — | |
| SCHEMBL1132282 | 0.83 | — | — | |
| SCHEMBL10123411 | 0.83 | — | — | |
| SCHEMBL10123412 | 0.83 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 26 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230372207-A1 | CARBONATED AEROSOL EXTERNAL PREPARATION FOR SKIN | KAO CORPORATION (JP) | 2023-11-23 | — | — | US | disclosed |
| US-20230372207-A1 | CARBONATED AEROSOL EXTERNAL PREPARATION FOR SKIN | KAO CORPORATION (JP) | 2023-11-23 | — | — | US | disclosed |
| US-11820789-B2 | Glycosylated sphingoid bases and production thereof | CARBOCODE S.A. (PT) | 2023-11-21 | — | — | US | disclosed |
| US-11730686-B2 | Cosmetic skincare compositions | THE BOOTS COMPANY PLC (GB) | 2023-08-22 | — | — | US | disclosed |
| US-11730686-B2 | Cosmetic skincare compositions | THE BOOTS COMPANY PLC (GB) | 2023-08-22 | — | — | US | disclosed |
| WO-2020250966-A1 | EMULSION COMPOSITION | 花王株式会社 | 2020-12-17 | — | — | WO | disclosed |
| US-9694076-B2 | Vesicle composition | KAO CORPORATION (JP) | 2017-07-04 | — | — | US | disclosed |
| US-9694076-B2 | Vesicle composition | KAO CORPORATION (JP) | 2017-07-04 | — | — | US | disclosed |
| US-20160166698-A1 | VESICLE COMPOSITION | KAO CORPORATION (JP) | 2016-06-16 | — | — | US | disclosed |
| US-9278059-B2 | Emulsified cosmetic composition | KAO CORPORATION (JP) | 2016-03-08 | — | — | US | disclosed |
| US-20120295989-A1 | OIL-BASED COMPOSITION | KAO CORPORATION (JP) | 2012-11-22 | — | — | US | disclosed |
| US-8178584-B2 | Sphingosines, fatty acid, and oil; improved stability and feel to skin | KAO CORPORATION (JP) | 2012-05-15 | — | — | US | disclosed |
| US-20120108661-A1 | EMULSIFIED COMPOSITION | KAO CORPORATION (JP) | 2012-05-03 | — | — | US | disclosed |
| US-20110263714-A1 | Reverse Vesicle | KAO CORPORATION (JP) | 2011-10-27 | — | — | US | disclosed |
| US-20110165658-A1 | PHOTOSYNTHETIC MICROORGANISMS ENRICHED IN SELENIUM USING SELENOHYDROXY ACID COMPOUNDS, USED THEREOF IN NUTRITION, COSMETICS AND PHARMACY | ECO SOLUTION (FR) | 2011-07-07 | — | — | US | disclosed |
| US-20110151545-A1 | NON-PHOTOSYNTHETIC MICRO-ORGANISMS ENRICHED WITH ORGANIC SELENIUM FROM SELENO-HYDROXYACID COMPOUNDS AND APPLICATIONS THEREOF IN THE FIELDS OF NUTRITION, COSMETICS AND PHARMACUEUTICALS | TETRAHEDRON | 2011-06-23 | — | — | US | disclosed |
| US-20100311836-A1 | OIL-IN-WATER EMULSIFIED COSMETIC COMPOSITION | KAO CORPORATION (JP) | 2010-12-09 | — | — | US | disclosed |
| US-7846969-B2 | Ceramide emulsions | KAO CORPORATION (JP) | 2010-12-07 | — | — | US | disclosed |
| EP-1778706-B1 | NEW SELENOHYDROXY ACIDS AND THEIR DERIVATIVES: APPLICATIONS IN NUTRITION, COSMETICS AND PHARMACEUTICS | TETRAHEDRON (FR) | 2009-07-08 | — | — | EP | disclosed |
| US-7381416-B2 | Selenohydroxy acids and their derivatives, applications in nutrition, cosmetics and pharmaceutics | TETRAHEDRON SAS (FR) | 2008-06-03 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (8 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11820789-B2 | Glycosylated sphingoid bases and production thereof | UGCG, CERT1, SGMS1 | LMNA 1301/4885CYP2D6 3308/4885MAPT 4396/4885 |
| US-20230372207-A1 | CARBONATED AEROSOL EXTERNAL PREPARATION FOR SKIN | CERT1, CERS2, SGMS2 | LMNA 390/4885CYP2D6 4725/4885MAPT 1954/4885 |
| US-20120295989-A1 | OIL-BASED COMPOSITION | SGMS1, SGMS2, F12 | LMNA 244/4885CYP2D6 3781/4885MAPT 3930/4885 |
| US-20160166698-A1 | VESICLE COMPOSITION | SGMS1, EXOSC10, SGMS2 | LMNA 3672/4885CYP2D6 3089/4885MAPT 3843/4885 |
| US-20100311836-A1 | OIL-IN-WATER EMULSIFIED COSMETIC COMPOSITION | CERT1, SGMS1, DEGS1 | LMNA 600/4885CYP2D6 2053/4885MAPT 4411/4885 |
| US-20120108661-A1 | EMULSIFIED COMPOSITION | CERT1, S1PR4, S1PR3 | LMNA 1152/4885CYP2D6 1746/4885MAPT 2740/4885 |
| US-20110263714-A1 | Reverse Vesicle | SGMS1, EXOSC10, SGMS2 | LMNA 380/4885CYP2D6 3441/4885MAPT 4614/4885 |
| US-11730686-B2 | Cosmetic skincare compositions | SPHK1, SPHK2, S1PR2 | LMNA 1281/4885CYP2D6 4815/4885MAPT 2412/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.